A detailed history of Israel Englander (Millennium Management LLC) transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 43,750 shares of CLDX stock, worth $1.21 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,750
Previous 208,251 78.99%
Holding current value
$1.21 Million
Previous $8.74 Million 81.48%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$32.76 - $42.56 $5.39 Million - $7 Million
-164,501 Reduced 78.99%
43,750 $1.62 Million
Q1 2024

May 15, 2024

BUY
$35.22 - $51.88 $6.95 Million - $10.2 Million
197,254 Added 1793.71%
208,251 $8.74 Million
Q4 2023

Feb 14, 2024

SELL
$22.61 - $40.65 $220,289 - $396,052
-9,743 Reduced 46.98%
10,997 $436,000
Q2 2023

Aug 14, 2023

BUY
$30.29 - $38.28 $628,214 - $793,927
20,740 New
20,740 $703,000
Q4 2022

Feb 14, 2023

BUY
$27.78 - $45.38 $954,270 - $1.56 Million
34,351 New
34,351 $1.53 Million
Q2 2022

Aug 15, 2022

BUY
$20.5 - $37.33 $730,661 - $1.33 Million
35,642 Added 33.09%
143,343 $3.87 Million
Q1 2022

May 16, 2022

BUY
$27.64 - $39.32 $1.88 Million - $2.67 Million
68,030 Added 171.49%
107,701 $3.67 Million
Q4 2021

Feb 14, 2022

BUY
$35.68 - $56.27 $1.42 Million - $2.23 Million
39,671 New
39,671 $1.53 Million
Q2 2021

Aug 16, 2021

SELL
$20.71 - $35.37 $10.5 Million - $17.9 Million
-505,163 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$16.19 - $29.91 $4.84 Million - $8.95 Million
299,241 Added 145.32%
505,163 $10.4 Million
Q4 2020

Feb 16, 2021

BUY
$14.99 - $22.75 $3.09 Million - $4.68 Million
205,922 New
205,922 $3.61 Million
Q3 2020

Nov 16, 2020

SELL
$9.65 - $15.19 $4.15 Million - $6.54 Million
-430,564 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$1.61 - $13.41 $693,208 - $5.77 Million
430,564 New
430,564 $5.6 Million

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.29B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.